Related Articles
Combinations of elevated tissue miRNA‑17‑92 cluster expression and serum prostate‑specific antigen as potential diagnostic biomarkers for prostate cancer
The auxiliary diagnostic value of prostate‑specific antigen and α‑methylacyl‑CoA racemase in prostate cancer
Blood‑based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer‑risk stratification
Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone
Progression of prostate cancer: Diagnostic and prognostic utility of prostate-specific antigen, α2-macroglobulin, and their complexes